Postoperative Analgesic Efficacy of Transversus Abdominis Plane in Laparoscopic Abdominal Surgeries

Postoperative Analgesic Efficacy of Transversus Abdominis Plane (Ultrasound Guided) in Laparoscopic Abdominal Surgeries Using Levobupivacaine with Dexmedetomidine Versus Placebo: Prospective Randomized Double Blinded Controlled Clinical Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201803003108330

Enrollment

Registered

2018-02-19

Start date

2018-02-04

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery Laparoscopic Abdominal Surgeries

Interventions

Group I (levobup.)

Group II (levobup. + Dex A)

Group III (levobup. + Dex B)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA I ¿ III of both sex, between 18 and 60 years undergoing laparoscopic abdominal surgeries

Exclusion criteria

Exclusion criteria: Open surgeries. - If the surgery proceeded to laparotomy. - BMI ¿ 35 Kg/m. - Known allergy or hypersensitivity against levobupivacaine, other amino-amide local anesthetics, or dexmedetomidine. - Coagulopathy; septicemia. - Abnormalities in ECG that are considered clinically relevant like AV block or bradycardia.

Design outcomes

Primary

Measure	Time frame
the duration of analgesia (time required to receive 1st dose of morphine)	—

Secondary

Measure	Time frame
the VAS score, and 24 hours morphine consumption	—

Countries

Egypt

Contacts

Public ContactMichael Elmansoury

MD, Sheikh Khalifa Medical City

mick_bengawy@hotmail.com+971561369900

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026